Pfizer Partner Faces Legal Challenge from GSK Over COVID-19 Vaccine Patent Claims

A new chapter unfolds in the burgeoning legal battle surrounding COVID-19 vaccines as a developer working with Pfizer and BioNTech launches a lawsuit against GlaxoSmithKline (GSK). The dispute is centered on allegations that Pfizer’s vaccine infringes upon patents held by the U.K.-based pharmaceutical giant GSK. This legal action adds to the ongoing complex landscape of intellectual property challenges faced by companies involved in the development and distribution of COVID-19 vaccines. As this case progresses, it will be crucial to monitor its implications for the pharmaceutical industry and patent law developments worldwide.